128 results
Page 3 of 7
8-K
EX-99.1
lemjm
5 Aug 20
Results of Operations and Financial Condition
7:01am
8-K
EX-99.1
kvj8l d86rv3p3650
7 May 20
Results of Operations and Financial Condition
7:00am
PRE 14A
qnbyid3 267in
19 Mar 20
Preliminary proxy
4:19pm
8-K
EX-99.1
s25l p2lszxa62
12 Feb 20
Results of Operations and Financial Condition
7:07am
8-K
EX-10.1
8o3shatqtmp
10 Apr 19
Entry into a Material Definitive Agreement
8:01am
10-K
9qcb7qj
12 Feb 18
Annual report
12:00am
424B5
g2jc1rzt09ut96c
18 Jul 16
Prospectus supplement for primary offering
12:00am
424B5
khmotxt kaw7o
30 Nov 15
Prospectus supplement for primary offering
12:00am
424B5
zhiwk 8xkw
30 Nov 15
Prospectus supplement for primary offering
12:00am
6-K
vn8ho1pbcb 5u6
30 Nov 15
Current report (foreign)
12:00am
6-K
EX-99.1
nlces3b8owsoevwm9s
27 Jul 15
Teva to Acquire Allergan Generics for $40.5 Billion
12:00am
6-K
EX-99.2
eisb1ukqnpanm5srk
27 Jul 15
Teva to Acquire Allergan Generics for $40.5 Billion
12:00am
425
bndzgy1txbmm
8 Jun 15
Business combination disclosure
12:00am
425
krzkzgft3g
21 Apr 15
Business combination disclosure
12:00am
425
8qokfb50
21 Apr 15
Business combination disclosure
12:00am